1. Home
  2. ANGI vs TARA Comparison

ANGI vs TARA Comparison

Compare ANGI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

N/A

Current Price

$4.78

Market Cap

198.7M

ML Signal

N/A

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$3.94

Market Cap

236.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANGI
TARA
Founded
1995
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.7M
236.1M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
ANGI
TARA
Price
$4.78
$3.94
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$17.00
$24.40
AVG Volume (30 Days)
776.8K
324.7K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
38.25
EPS
N/A
N/A
Revenue
$736,386,000.00
$2,948,000.00
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.60
N/A
52 Week Low
$4.26
$3.02
52 Week High
$18.38
$7.82

Technical Indicators

Market Signals
Indicator
ANGI
TARA
Relative Strength Index (RSI) 46.11 47.37
Support Level $4.57 $3.73
Resistance Level $6.52 $4.17
Average True Range (ATR) 0.31 0.14
MACD 0.05 0.01
Stochastic Oscillator 36.84 50.65

Price Performance

Historical Comparison
ANGI
TARA

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: